Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Changes of PACAP level in cerebrospinal fluid and plasma of patients with severe traumatic brain injury.

Bukovics P, Czeiter E, Amrein K, Kovacs N, Pal J, Tamas A, Bagoly T, Helyes Z, Buki A, Reglodi D.

Peptides. 2014 Oct;60:18-22. doi: 10.1016/j.peptides.2014.07.001. Epub 2014 Jul 10.

PMID:
25017241
2.

The change of plasma pituitary adenylate cyclase-activating polypeptide levels after aneurysmal subarachnoid hemorrhage.

Jiang L, Wang WH, Dong XQ, Yu WH, Du Q, Yang DB, Wang H, Shen YF.

Acta Neurol Scand. 2016 Aug;134(2):131-9. doi: 10.1111/ane.12522. Epub 2015 Oct 16.

PMID:
26471292
3.

Activin a release into cerebrospinal fluid in a subset of patients with severe traumatic brain injury.

Phillips DJ, Nguyen P, Adamides AA, Bye N, Rosenfeld JV, Kossmann T, Vallance S, Murray L, Morganti-Kossmann MC.

J Neurotrauma. 2006 Sep;23(9):1283-94.

PMID:
16958581
4.

TGF-beta is elevated in the CSF of patients with severe traumatic brain injuries and parallels blood-brain barrier function.

Morganti-Kossmann MC, Hans VH, Lenzlinger PM, Dubs R, Ludwig E, Trentz O, Kossmann T.

J Neurotrauma. 1999 Jul;16(7):617-28.

PMID:
10447073
5.

Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury.

Shiozaki T, Hayakata T, Tasaki O, Hosotubo H, Fuijita K, Mouri T, Tajima G, Kajino K, Nakae H, Tanaka H, Shimazu T, Sugimoto H.

Shock. 2005 May;23(5):406-10.

PMID:
15834305
6.
7.

Dynamics of S100B release into serum and cerebrospinal fluid following acute brain injury.

Kleindienst A, Meissner S, Eyupoglu IY, Parsch H, Schmidt C, Buchfelder M.

Acta Neurochir Suppl. 2010;106:247-50. doi: 10.1007/978-3-211-98811-4_46.

PMID:
19812958
8.

Vascular endothelial growth factor is increased in cerebrospinal fluid after traumatic brain injury in infants and children.

Shore PM, Jackson EK, Wisniewski SR, Clark RS, Adelson PD, Kochanek PM.

Neurosurgery. 2004 Mar;54(3):605-11; discussion 611-2.

PMID:
15028134
9.

Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury.

Hayakata T, Shiozaki T, Tasaki O, Ikegawa H, Inoue Y, Toshiyuki F, Hosotubo H, Kieko F, Yamashita T, Tanaka H, Shimazu T, Sugimoto H.

Shock. 2004 Aug;22(2):102-7.

PMID:
15257081
10.

Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury.

Pineda JA, Lewis SB, Valadka AB, Papa L, Hannay HJ, Heaton SC, Demery JA, Liu MC, Aikman JM, Akle V, Brophy GM, Tepas JJ, Wang KK, Robertson CS, Hayes RL.

J Neurotrauma. 2007 Feb;24(2):354-66.

PMID:
17375999
11.

Plasma pituitary adenylate cyclase-activating polypeptide concentrations and mortality after acute spontaneous basal ganglia hemorrhage.

Ma BQ, Zhang M, Ba L.

Clin Chim Acta. 2015 Jan 15;439:102-6. doi: 10.1016/j.cca.2014.10.010. Epub 2014 Oct 12.

PMID:
25314937
12.

αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients.

Mondello S, Robicsek SA, Gabrielli A, Brophy GM, Papa L, Tepas J, Robertson C, Buki A, Scharf D, Jixiang M, Akinyi L, Muller U, Wang KK, Hayes RL.

J Neurotrauma. 2010 Jul;27(7):1203-13. doi: 10.1089/neu.2010.1278.

13.

S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injury.

Goyal A, Failla MD, Niyonkuru C, Amin K, Fabio A, Berger RP, Wagner AK.

J Neurotrauma. 2013 Jun 1;30(11):946-57. doi: 10.1089/neu.2012.2579.

14.

α-Synuclein in CSF of patients with severe traumatic brain injury.

Mondello S, Buki A, Italiano D, Jeromin A.

Neurology. 2013 Apr 30;80(18):1662-8. doi: 10.1212/WNL.0b013e3182904d43. Epub 2013 Apr 3.

PMID:
23553480
15.

Cellular localization of pituitary adenylate cyclase-activating peptide (PACAP) following traumatic brain injury in humans.

van Landeghem FK, Weiss T, Oehmichen M, von Deimling A.

Acta Neuropathol. 2007 Jun;113(6):683-93. Epub 2007 Mar 13.

PMID:
17431645
16.

Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury.

Franz G, Beer R, Kampfl A, Engelhardt K, Schmutzhard E, Ulmer H, Deisenhammer F.

Neurology. 2003 May 13;60(9):1457-61.

PMID:
12743231
17.

Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children.

Berger RP, Pierce MC, Wisniewski SR, Adelson PD, Clark RS, Ruppel RA, Kochanek PM.

Pediatrics. 2002 Feb;109(2):E31.

PMID:
11826241
18.

Peripheral and central alterations of pituitary adenylate cyclase activating polypeptide-like immunoreactivity in the rat in response to activation of the trigeminovascular system.

Tuka B, Helyes Z, Markovics A, Bagoly T, Németh J, Márk L, Brubel R, Reglődi D, Párdutz A, Szolcsányi J, Vécsei L, Tajti J.

Peptides. 2012 Feb;33(2):307-16. doi: 10.1016/j.peptides.2011.12.019. Epub 2012 Jan 8.

PMID:
22245521
19.

Ubiquitin immunoreactivity in cerebrospinal fluid after traumatic brain injury: clinical and experimental findings.

Majetschak M, King DR, Krehmeier U, Busby LT, Thome C, Vajkoczy S, Proctor KG.

Crit Care Med. 2005 Jul;33(7):1589-94.

PMID:
16003067
20.

Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients.

Tuka B, Helyes Z, Markovics A, Bagoly T, Szolcsányi J, Szabó N, Tóth E, Kincses ZT, Vécsei L, Tajti J.

Cephalalgia. 2013 Oct;33(13):1085-95. doi: 10.1177/0333102413483931. Epub 2013 Apr 18.

PMID:
23598374

Supplemental Content

Support Center